Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Gynecology

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 68 articles:
HTML format
Text format



Single Articles


    March 2019
  1. ZHAO F, Qiao Y
    Cervical cancer prevention in China: a key to cancer control.
    Lancet. 2019;393:969-970.
    PubMed     Text format    


    February 2019
  2. KLEBANOFF MA
    Interpregnancy interval after stillbirth: modifiable, but does it matter?
    Lancet. 2019 Feb 28. pii: S0140-6736(18)32430.
    PubMed     Text format    


  3. REGAN AK, Gissler M, Magnus MC, Haberg SE, et al
    Association between interpregnancy interval and adverse birth outcomes in women with a previous stillbirth: an international cohort study.
    Lancet. 2019 Feb 28. pii: S0140-6736(18)32266.
    PubMed     Text format     Abstract available


  4. KIOKO PM, Meana PR
    Abortion in Argentina.
    Lancet. 2019;393:745.
    PubMed     Text format    


  5. GARCIA G
    Abortion in Argentina.
    Lancet. 2019;393:744.
    PubMed     Text format    


  6. UZOIGWE CE
    Abortion in Argentina.
    Lancet. 2019;393:744-745.
    PubMed     Text format    


  7. OVADIA C, Seed PT, Sklavounos A, Geenes V, et al
    Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses.
    Lancet. 2019 Feb 14. pii: S0140-6736(18)31877.
    PubMed     Text format     Abstract available


  8. PALMER KR, Xiaohua L, Mol BW
    Management of intrahepatic cholestasis in pregnancy.
    Lancet. 2019 Feb 14. pii: S0140-6736(18)32323.
    PubMed     Text format    


  9. REPPING S
    Evidence-based medicine and infertility treatment.
    Lancet. 2019;393:380-382.
    PubMed     Text format    


  10. MILLER D, Pavitt S, Sharma V, Forbes G, et al
    Physiological, hyaluronan-selected intracytoplasmic sperm injection for infertility treatment (HABSelect): a parallel, two-group, randomised trial.
    Lancet. 2019;393:416-422.
    PubMed     Text format     Abstract available


    January 2019
  11. HOFMEYR GJ, Betran AP, Singata-Madliki M, Cormick G, et al
    Prepregnancy and early pregnancy calcium supplementation among women at high risk of pre-eclampsia: a multicentre, double-blind, randomised, placebo-controlled trial.
    Lancet. 2019;393:330-339.
    PubMed     Text format     Abstract available


  12. BUJOLD E, Hyett J
    Calcium supplementation for prevention of pre-eclampsia.
    Lancet. 2019;393:298-300.
    PubMed     Text format    


  13. COHEN PA, Jhingran A, Oaknin A, Denny L, et al
    Cervical cancer.
    Lancet. 2019;393:169-182.
    PubMed     Text format     Abstract available


  14. THE LANCET
    Cervical cancer: unequal progress.
    Lancet. 2019;393:104.
    PubMed     Text format    


    December 2018
  15. BERNITZ S, Dalbye R, Zhang J, Eggebo TM, et al
    The frequency of intrapartum caesarean section use with the WHO partograph versus Zhang's guideline in the Labour Progression Study (LaPS): a multicentre, cluster-randomised controlled trial.
    Lancet. 2018 Dec 20. pii: S0140-6736(18)31991.
    PubMed     Text format     Abstract available


  16. DIAZ-GARCIA C, Pellicer A
    Uterus transplantation from a deceased donor.
    Lancet. 2018 Dec 4. pii: S0140-6736(18)32106.
    PubMed     Text format    


  17. EJZENBERG D, Andraus W, Baratelli Carelli Mendes LR, Ducatti L, et al
    Livebirth after uterus transplantation from a deceased donor in a recipient with uterine infertility.
    Lancet. 2018 Dec 4. pii: S0140-6736(18)31766.
    PubMed     Text format     Abstract available


    November 2018
  18. THE LANCET
    Addressing preventable stillbirth and brain injury.
    Lancet. 2018;392:2238.
    PubMed     Text format    


    October 2018
  19. FARQUHAR C
    Unexplained infertility - Authors' reply.
    Lancet. 2018;392:1517.
    PubMed     Text format    


  20. GLEICHER N, Kuhnir VA, Barad DH
    Unexplained infertility.
    Lancet. 2018;392:1516-1517.
    PubMed     Text format    


  21. HOCKING JS, Temple-Smith M, Guy R, Donovan B, et al
    Population effectiveness of opportunistic chlamydia testing in primary care in Australia: a cluster-randomised controlled trial.
    Lancet. 2018;392:1413-1422.
    PubMed     Text format     Abstract available


  22. ADAMSON PC, Klausner JD
    No benefit of chlamydia screening in primary care?
    Lancet. 2018;392:1381-1383.
    PubMed     Text format    


  23. SUBTIL D, Brabant G, Tilloy E, Devos P, et al
    Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial.
    Lancet. 2018 Oct 12. pii: S0140-6736(18)31617.
    PubMed     Text format     Abstract available


  24. KLEBANOFF MA, Brotman RM
    Treatment of bacterial vaginosis to prevent preterm birth.
    Lancet. 2018 Oct 12. pii: S0140-6736(18)32115.
    PubMed     Text format    


    September 2018
  25. TEMMERMAN M, Lawn JE
    Stillbirths count, but it is now time to count them all.
    Lancet. 2018 Sep 27. pii: S0140-6736(18)32342.
    PubMed     Text format    


  26. SMITH LK, Hindori-Mohangoo AD, Delnord M, Durox M, et al
    Quantifying the burden of stillbirths before 28 weeks of completed gestational age in high-income countries: a population-based study of 19 European countries.
    Lancet. 2018 Sep 27. pii: S0140-6736(18)31651.
    PubMed     Text format     Abstract available


    August 2018
  27. GRESSLER LE, Titus-Glover D, Shaya FT
    Treatment modalities for pregnant women with opioid use disorder.
    Lancet. 2018;392:551.
    PubMed     Text format    


  28. SEN A, Nashef L
    New regulations to cut valproate-exposed pregnancies.
    Lancet. 2018;392:458-460.
    PubMed     Text format    


    July 2018
  29. GHOSN J, Taiwo B, Seedat S, Autran B, et al
    HIV.
    Lancet. 2018 Jul 23. pii: S0140-6736(18)31311.
    PubMed     Text format     Abstract available


  30. THE LANCET
    Cervical cancer prevention in Thailand-a model of success.
    Lancet. 2018;392:2.
    PubMed     Text format    


    June 2018
  31. LI A
    From Ireland to Northern Ireland: campaigns for abortion law.
    Lancet. 2018;391:2403-2404.
    PubMed     Text format    


  32. BOOTH A
    Argentina votes on bill to legalise abortion up to 14 weeks.
    Lancet. 2018;391:e21-e22.
    PubMed     Text format    


  33. THE LANCET
    Dolutegravir for HIV: a lesson in pregnancy safety research.
    Lancet. 2018;391:2296.
    PubMed     Text format    


    May 2018
  34. HALLGARTEN L
    Abortion narratives: moving from statistics to stories.
    Lancet. 2018 May 8. pii: S0140-6736(18)31036.
    PubMed     Text format    


  35. SPERBER A
    El Salvador's total ban on abortion risks women's health.
    Lancet. 2018;391:1758-1759.
    PubMed     Text format    


    April 2018
  36. BARNETT R
    Syphilis.
    Lancet. 2018;391:1471.
    PubMed     Text format    


    March 2018
  37. THE LANCET
    Diagnosis of heavy menstrual bleeding: a change in direction.
    Lancet. 2018;391:1122.
    PubMed     Text format    


  38. THE LANCET
    Abortion: access and safety worldwide.
    Lancet. 2018;391:1121.
    PubMed     Text format    


  39. WATTS G
    New York Challenge sets high bar for HPV vaccination.
    Lancet. 2018;391:1137.
    PubMed     Text format    


    February 2018
  40. MUSALLAM R, Salem N, Al Halol R, Al Deeb H, et al
    Management of pregnancy loss in the first trimester: a retrospective audit.
    Lancet. 2018;391 Suppl 2:S34.
    PubMed     Text format     Abstract available


  41. HABABEH M, Zeidan W, El-Kader MA, Thaher AA, et al
    Contraceptive use by Palestine refugee mothers of young children attending UNRWA clinics: a cross-sectional follow-up study.
    Lancet. 2018;391 Suppl 2:S26.
    PubMed     Text format     Abstract available


  42. KATEEB E, Momany E
    Factors related to high dental caries experience in Palestinian pregnant women in the Jerusalem governorate: a cross-sectional study.
    Lancet. 2018;391 Suppl 2:S11.
    PubMed     Text format     Abstract available


  43. LARSON HJ
    A global girl gang.
    Lancet. 2018;391:527-528.
    PubMed     Text format    


  44. DEVI S
    FGM in Sierra Leone.
    Lancet. 2018;391:415.
    PubMed     Text format    


    December 2017
  45. WEISS NS, Nahuis MJ, Bordewijk E, Oosterhuis JE, et al
    Gonadotrophins versus clomifene citrate with or without intrauterine insemination in women with normogonadotropic anovulation and clomifene failure (M-OVIN): a randomised, two-by-two factorial trial.
    Lancet. 2017 Dec 19. pii: S0140-6736(17)33308.
    PubMed     Text format     Abstract available


  46. CAHILL N, Sonneveldt E, Stover J, Weinberger M, et al
    Modern contraceptive use, unmet need, and demand satisfied among women of reproductive age who are married or in a union in the focus countries of the Family Planning 2020 initiative: a systematic analysis using the Family Planning Estimation Tool.
    Lancet. 2017 Dec 4. pii: S0140-6736(17)33104.
    PubMed     Text format     Abstract available


  47. KVASKOFF M, Horne AW, Missmer SA
    Informing women with endometriosis about ovarian cancer risk.
    Lancet. 2017;390:2433-2434.
    PubMed     Text format    


    November 2017
  48. GHORANI E, Kaur B, Fisher RA, Short D, et al
    Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia.
    Lancet. 2017;390:2343-2345.
    PubMed     Text format    


  49. NANDI A, El-Toukhy T
    Stimulated intrauterine insemination for unexplained subfertility.
    Lancet. 2017 Nov 23. pii: S0140-6736(17)33038.
    PubMed     Text format    


  50. FARQUHAR CM, Liu E, Armstrong S, Arroll N, et al
    Intrauterine insemination with ovarian stimulation versus expectant management for unexplained infertility (TUI): a pragmatic, open-label, randomised, controlled, two-centre trial.
    Lancet. 2017 Nov 23. pii: S0140-6736(17)32406.
    PubMed     Text format     Abstract available


  51. KENDLER DL, Marin F, Zerbini CAF, Russo LA, et al
    Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial.
    Lancet. 2017 Nov 9. pii: S0140-6736(17)32137.
    PubMed     Text format     Abstract available


  52. MABEY D, Marks M, Peeling R, Lawn J, et al
    Stillbirth caused by syphilis remains a major global health problem.
    Lancet. 2017;390:2036.
    PubMed     Text format    


  53. HEININGER U
    Syphilis in children.
    Lancet. 2017;390:2035-2036.
    PubMed     Text format    


    October 2017
  54. REGAN L, Glasier A
    The British 1967 Abortion Act-still fit for purpose?
    Lancet. 2017;390:1936-1937.
    PubMed     Text format    


  55. YIN Y
    HPV vaccination in China needs to be more cost-effective.
    Lancet. 2017;390:1735-1736.
    PubMed     Text format    


    September 2017
  56. CASASSUS B
    Contraception implant removed from global market.
    Lancet. 2017;390:1576.
    PubMed     Text format    


  57. GEMZELL-DANIELSSON K, Cleeve A
    Estimating abortion safety: advancements and challenges.
    Lancet. 2017 Sep 27. pii: S0140-6736(17)32135.
    PubMed     Text format    


  58. GANATRA B, Gerdts C, Rossier C, Johnson BR Jr, et al
    Global, regional, and subregional classification of abortions by safety, 2010-14: estimates from a Bayesian hierarchical model.
    Lancet. 2017 Sep 27. pii: S0140-6736(17)31794.
    PubMed     Text format     Abstract available


  59. GARG SK, Polsky S
    Continuous glucose monitoring in pregnant women with type 1 diabetes.
    Lancet. 2017 Sep 14. pii: S0140-6736(17)32449.
    PubMed     Text format    


  60. FEIG DS, Donovan LE, Corcoy R, Murphy KE, et al
    Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial.
    Lancet. 2017 Sep 14. pii: S0140-6736(17)32400.
    PubMed     Text format     Abstract available


  61. DIZON DS
    PARP inhibitors for targeted treatment in ovarian cancer.
    Lancet. 2017 Sep 12. pii: S0140-6736(17)32418.
    PubMed     Text format    


  62. COLEMAN RL, Oza AM, Lorusso D, Aghajanian C, et al
    Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Lancet. 2017 Sep 12. pii: S0140-6736(17)32440.
    PubMed     Text format     Abstract available


  63. DENNY L
    Nine-valent human papillomavirus vaccine: great science, but will it save lives?
    Lancet. 2017 Sep 5. pii: S0140-6736(17)32144.
    PubMed     Text format    


  64. HUH WK, Joura EA, Giuliano AR, Iversen OE, et al
    Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial.
    Lancet. 2017 Sep 5. pii: S0140-6736(17)31821.
    PubMed     Text format     Abstract available


    July 2017
  65. BANERJEE S
    Bevacizumab in cervical cancer: a step forward for survival.
    Lancet. 2017 Jul 27. pii: S0140-6736(17)31965.
    PubMed     Text format    


  66. TEWARI KS, Sill MW, Penson RT, Huang H, et al
    Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240).
    Lancet. 2017 Jul 27. pii: S0140-6736(17)31607.
    PubMed     Text format     Abstract available


    April 2017
  67. THE LANCET
    Syphilis: an ancient disease in a modern era.
    Lancet. 2017;389:1492.
    PubMed     Text format    


    December 2016
  68. HOOK EW RD
    Syphilis.
    Lancet. 2016 Dec 16. pii: S0140-6736(16)32411.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: